All In Biotech

Free tool

FAERS Monitor: Cerebyx

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020450 or its brand name (Cerebyx, Fosphenytoin Sodium). Reports on generic versions are filed under their own applications.

Reports

1,017

Serious

884

87% of reports

Hospitalization

387

Death reported

164

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective127
  • off label use70
  • hypotension50
  • status epilepticus49
  • cardiac arrest48
  • seizure44
  • convulsion41
  • pyrexia41
  • stevens-johnson syndrome34
  • blood pressure decreased30
  • toxicity to various agents29
  • drug interaction26
  • overdose24
  • bradycardia23
  • medication error23

Reports by year received

View as table
YearReports
200436
200533
200650
200728
200828
200913
201020
201122
201254
201371
201472
201568
201668
201789
201841
201916
202039
202133
202268
202359
202447
202537
202625

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,142 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
status epilepticusSignal4990.168.64,215
stevens-johnson syndromeSignal3431.722.7979
convulsionSignal4114.811.0516
cardiac arrestSignal4812.09.1476
blood pressure decreasedSignal309.36.6216
bradycardiaSignal239.06.0155
medication errorSignal238.65.7146
seizureSignal447.95.9259
hypotensionSignal505.23.9165
toxicity to various agentsSignal293.62.551
drug interactionSignal263.42.342
pyrexiaSignal412.51.834
overdoseSignal242.31.517
drug ineffective1272.01.766
off label use701.71.318

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.